FXYD6 and central nervous system neoplasm: According to 2021 WHO CNS tumor classification,40 similarly, we still did not find statistical significance of OS about different FXYD6 expression in Astrocytoma (IDH mutant, WHO Grade IV) and GBM (IDH wildtype).